Sanofi (SNY) Reports Q4 Revenues of EUR9.61B
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Drugmaker Sanofi expects further profit growth from narrowed focus
February 6, 2020 1:51 AM ESTBy Matthias Blamont
PARIS (Reuters) - French drugmaker Sanofi on Thursday forecast further profit growth for 2020 even as it drops some research in areas such as diabetes in a shake-up to narrow its focus on blockbuster treatments including eczema medicine Dupixent.
Sanofi, long viewed as a laggard in the pharmaceutical sector, has changed its chief executive, its chief financial officer and head of research over the past two years and is hoping to shine again thanks to the pipeline shake-up and cost cuts.
The company... More
Sanofi investigated over epilepsy drug linked to birth defects
February 4, 2020 2:07 AM ESTPARIS (Reuters) - French drugmaker Sanofi said on Tuesday it was being investigated over Depakine, an epilepsy drug which caused birth malfunctions and slow neurological development when taken during pregnancy.
The Paris prosecutor had already launched a preliminary investigation into the authorization and marketing of Depakine in 2016, after France's social affairs inspection agency IGAS criticized the slow response of health authorities and Sanofi to the risks related to the drug and its derivatives.
Sanofi said in a statement that the indictment, which may or may not lead to a... More
